Trends in Cardiovascular Medicine
Volume 16, Issue 4 , Pages 103-108 , May 2006

SDF-1α-Mediated Tissue Repair by Stem Cells: A Promising Tool in Cardiovascular Medicine?

References 

  1. Abbott DJ, Huang Y, Liu D, et al. SDF-1α plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004;110:3300–3305
  2. Abi-Younes S, Sauty A, Mach F, et al. The SDF-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res. 2000;86:131–138
  3. Aiuti A, Webb IJ, Bleul C, et al. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med. 1997;185:111–120
  4. Ara T, Tokoyoda K, Okamoto R, et al. The role of CXCL12 in the organ-specific process of artery formation. Blood. 2005;105:3155–3161
  5. Askari AT, Unzek S, Popovic ZB, et al. Effect of SDF-1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet. 2003;362:697–703
  6. Avecilla ST, Hattori K, Heissig B, et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med. 2004;10:64–71
  7. Bleul CC, Fuhlbrigge RC, Casasnovas JM, et al. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996;184:1101–1109
  8. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature. 1996;382:829–833
  9. Blau HM, Brazelton TR, Weimann JM. The evolving concept of a stem cell: entity or function?. Cell. 2001;105:829–841
  10. Ceradini D, Kulkarni A, Callaghan M, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10:858–864
  11. Coffield VM, Jiang Q, Su L. A genetic approach to inactivating chemokine receptors using a modified viral protein. Nat Biotechnol. 2003;21:1321–1327
  12. Crump MP, Gong JH, Loetscher P, et al. Solution structure and basis for functional activity of SDF-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 1997;16:6996–7007
  13. Damas JK, Waehre T, Yndestad A, et al. SDF-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation. 2002;106:36–42
  14. Delgado MB, Clark-Lewis I, Loetscher P, et al. Rapid inactivation of SDF-1 by cathepsin G associated with lymphocytes. Eur J Immunol. 2001;31:699–707
  15. Fedyk ER, Jones D, Critchley HO, et al. Expression of SDF-1 is decreased by IL-1 and TNF and in dermal wound healing. J Immunol. 2001;166:5749–5754
  16. Ganju RK, Brubaker SA, Meyer J, et al. The alpha-chemokine, SDF-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem. 1998;273:23169–23175
  17. Gupta SK, Lysko PG, Pillarisetti K, et al. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem. 1998;273:4282–4287
  18. Hattori K, Heissig B, Tashiro K, et al. Plasma elevation of SDF-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood. 2001;97:3354–3360
  19. Heissig B, Hattori K, Dias S, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell. 2002;109:625–637
  20. Hiasa K, Ishibashi M, Ohtani K, et al. Gene transfer of SDF-1α enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation. 2004;109:2454–2461
  21. Hillebrands JL, Klatter FA, Rozing J. Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. Arterioscler Thromb Vasc Biol. 2003;23:380–387
  22. Janowska-Wieczorek A, Majka M, Rozing J, et al. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood. 2001;98:3143–3149
  23. Kollet O, Shivtiel S, Chen YQ, et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest. 2003;112:160–169
  24. Kucia M, Dawn B, Hunt G, et al. Cells expressing early cardiac markers reside in the bone marrow and are mobilized into the peripheral blood after myocardial infarction. Circ Res. 2004;95:1191–1199
  25. Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity. 1999;10:463–471
  26. Murphy PM, Baggiolini M, Charo IF, et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev. 2000;52:145–176
  27. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 1996;382:635–638
  28. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 1996;382:833–835
  29. Orsini M, Parent JL, Stuart J, et al. Trafficking of the HIV coreceptor CXCR4. Role of arrestins and identification of residues in the c-terminal tail that mediate receptor internalization. J Biol Chem. 1999;274:31076–31086
  30. Peled A, Grabovsky V, Habler L, et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. J Clin Invest. 1999;104:1199–1211
  31. Peled A, Petit I, Kollet O, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283:845–848
  32. Ponomaryov T, Peled A, Petit I, et al. Induction of the chemokine SDF-1 following DNA damage improves human stem cell function. J Clin Invest. 2000;106:1331–1339
  33. Proost P, Struyf S, Schols D, et al. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of SDF-1alpha. FEBS Lett. 1998;432:73–76
  34. Sadir R, Baleux F, Grosdidier A, et al. Characterization of the SDF-1alpha-heparin complex. J Biol Chem. 2001;276:8288–8296
  35. Sakihama H, Masunaga T, Yamashita K, et al. SDF-1 and CXCR4 interaction is critical for development of transplant arteriosclerosis. Circulation. 2004;110:2924–2930
  36. Salcedo R, Wasserman K, Young HA, et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by SDF-1 alpha. Am J Pathol. 1999;154:1125–1135
  37. Salvucci O, Yao L, Villalba S, et al. Regulation of endothelial cell branching morphogenesis by endogenous chemokine SDF-1. Blood. 2002;99:2703–2711
  38. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002;8:403–409
  39. Schober A, Knarren S, Lietz M, et al. Crucial role of SDF-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation. 2003;108:2491–2497
  40. Shirozu M, Nakano T, Inazawa J, et al. Structure and chromosomal localization of the human SDF-1 gene. Genomics. 1995;28:495–500
  41. Tachibana K, Hirota S, Iizasa H, et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature. 1998;393:591–594
  42. Tanaka K, Sata M, Hirata Y, et al. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res. 2003;93:783–790
  43. Tashiro K, Tada H, Heilker R, et al. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science. 1993;261:600–603
  44. Togel F, Isaac J, Hu Z, et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int. 2005;67:1772–1784
  45. Vila-Coro A, Rodriguez-Frade JM, Martin de Ana A, et al. The chemokine SDF-1α triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 1999;13:1699–1710
  46. Weber C, Zernecke A, Schober A. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol. 2004;24:1997–2008
  47. Whetton AD, Graham GJ. Homing and mobilization in the stem cell niche. Trends Cell Biol. 1999;9:233–238
  48. Yamaguchi J, Fukushima Kusano K, Masuo O, et al. SDF-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation. 2003;107:1322–1328
  49. Yamani MH, Ratliff NB, Cook DJ, et al. Peritransplant ischemic injury is associated with up-regulation of SDF-1. J Am Coll Cardiol. 2005;46:1029–1035
  50. Zeiffer U, Schober A, Lietz M, et al. Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines. Circ Res. 2004;94:776–784
  51. Zernecke A, Schober A, Bot I, et al. SDF-1α/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ. Res. 2005;96:784–791
  52. Zou YR, Kottmann AH, Kuroda M, et al. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 1998;393:595–599

PII: S1050-1738(06)00019-3

doi: 10.1016/j.tcm.2006.01.006

Trends in Cardiovascular Medicine
Volume 16, Issue 4 , Pages 103-108 , May 2006

Article Tools

* Image Usage & Resolution